Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Friday, November 10, 2017
Inscopix has partnered with Brains On-Line to advance the application of neural circuit mapping technology into the pharmaceutical CRO market.
read more
Wednesday, September 26, 2012
INDIGO Biosciences Inc., the premier provider of nuclear receptor products and services for the drug discovery and biosciences industries, has launched its new branding, “KNOW INDIGO,” and tagline, “The Nuclear Receptor Experts.”
read more
ImaBiotech Group announced the creation of an innovative global bioanalytical CRO with Pyxant Labs Inc. Colorado Springs and Salt Lake City sites. The integration of the expertise, innovation and analytical platforms of the companies to form a ...
read more
IGI Laboratories, Inc. (NYSE MKT: IG), a New Jersey based generic topical pharmaceutical company, today announced that it has received tentative approval from the U.S. Food & Drug Administration (FDA) for its abbreviated new drug application (ANDA) ...
read more
IGI Laboratories, Inc., a New Jersey based generic topical pharmaceutical company, today announced it has submitted its third abbreviated new drug application (ANDA) in 2013 to the U.S. Food and Drug Administration (FDA), which brings the Company’s ...
read more
IGI Laboratories, Inc. (NYSE Amex: IG), a New Jersey based pharmaceutical company, today announced that Jason Grenfell-Gardner has been appointed President and Chief Executive Officer of IGI Laboratories, Inc. effective July 30, 2012.
read more
Completing a major expansion of its biologics and vaccines production facility in Germany late last year, IDT Biologika established highly automated filling and freeze-drying operations, establishing the basis for large scale commercial manufacturing...
read more
ICON (NASDAQ: ICLR) (ISIN:IE0005711209), a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, today reported its financial results for the first quarter ended March 31, 2012.
read more
ICON plc, a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, today announced details of its participation at the International Society for Pharmacoeconomics and Outcomes Research (...
read more
ICON plc has made the following appointments:
Dr. Susan Anton, Director, Epidemiology and Risk Management Practice, ICON Late Phase & Outcomes Research
Dr. Susan Anton comes to ICON with over 25 years of experience leading international ...
read more
Tuesday, January 28, 2014
a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, today announced the appointment of Dr. Dariush Elahi as Director of Metabolic Research. Based in ICON’s Clinical Pharmacology ...
read more
Tuesday, February 28, 2012
ICON plc, a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, today announced the acquisition of PriceSpective LLC, a global leader in value strategy consulting. The acquisition ...
read more
Thursday, August 15, 2013
Nuevolution A/S today announced that it has entered into a scientific collaboration with Duke University, the Howard Hughes Medical Institute, and Lexicon Pharmaceuticals, Inc. for the investigation of the biological mechanism of action of a ...
read more
Monday, November 17, 2014
Horizon Discovery Group plc (LSE: HZD) (Horizon), a leading provider of research tools to support translational genomics, , has today announced the formation of a new Scientific Advisory Board (SAB) for its Diagnostics Business Unit (Horizon ...
read more
Friday, December 13, 2013
Okochi will have full profit and loss responsibility as well as overall accountability for all aspects of the Harlan Contract Research Services (CRS) business stream serving the Japanese chemical, agrochemical and pharmaceutical markets.
read more